These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2272050)

  • 21. Circadian-based effects of AcSDKP, with or without rhG-CSF on hematologic toxicity of chemotherapy in mice.
    Li XM; Soulard C; Filipski E; Deschamps de Paillette E; Lévi F
    Eur J Haematol; 1998 Mar; 60(3):181-8. PubMed ID: 9548417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dimer of hemoregulatory peptide (HP5B) stimulates mouse and human myelopoiesis in vitro.
    Laerum OD; Sletvold O; Bjerknes R; Eriksen JA; Johansen JH; Schanche JS; Tveterås T; Paukovits WR
    Exp Hematol; 1988 May; 16(4):274-80. PubMed ID: 3258825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of enriched stem cells in vivo and in vitro by the hemoregulatory peptide SK&F108636.
    Veiby OP; LoCastro S; Bhatnagar P; Olsen WM
    Stem Cells; 1996 Mar; 14(2):215-24. PubMed ID: 8991541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow stromal dysfunction in mice administered cytosine arabinoside.
    Ben-Ishay Z; Barak V
    Eur J Haematol; 2001 Apr; 66(4):230-7. PubMed ID: 11380602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating myeloid progenitor cell kinetics during hematologic recovery from chemotherapy and subsequent recombinant human granulocyte-macrophage colony-stimulating factor administration.
    Ventura GJ; Reading CL; Hester JP; Vadhan-Raj S
    Acta Haematol; 1990; 84(4):175-81. PubMed ID: 2125781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppressive biological activity of a synthetic pentapeptide on highly enriched human and murine marrow hematopoietic progenitors: synergism with recombinant human tumor necrosis factor-alpha and interferon-gamma.
    Lu L; Foa P; Chillemi F; Shen RN; Lin ZH; Carow C; Broxmeyer HE
    Exp Hematol; 1989 Oct; 17(9):935-41. PubMed ID: 2506072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modification of mouse hemopoietic cell proliferation in vivo by a hemoregulatory pentapeptide (HP 5b). Relation to circadian rhythms.
    Laerum OD; Paukovits WR
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1984; 46(4):333-48. PubMed ID: 6150578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Goralatide (AcSDKP) selectively protects murine hematopoietic progenitors and stem cells against hyperthermic damage.
    Wierenga PK; Konings AW
    Exp Hematol; 1996 Feb; 24(2):246-52. PubMed ID: 8641348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemoregulatory peptide (HP5b) dimer effects on normal and malignant cells in culture.
    Frostad S; Kalland T; Aakvaag A; Laerum OD
    Stem Cells; 1993 Jul; 11(4):303-11. PubMed ID: 8401253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of chemotherapy on bone marrow stroma in mice with acute myelogenous leukemia. Correlation with CFU-C and CFU-D.
    Ben-Ishay Z; Prindull G; Sharon S; Borenstein A
    Leuk Res; 1985; 9(8):1059-67. PubMed ID: 3862923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic manipulation of cytokines: transforming growth factor beta-1 protects mice treated with lethal doses of cytarabine.
    Pierce DF; Coffey RJ
    Am Surg; 1994 Jan; 60(1):18-25. PubMed ID: 8273969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced tumor load reduction after chemotherapy induced recruitment and synchronization in a slowly growing rat leukemia model (BNML) for human acute myelocytic leukemia.
    Colly LP; van Bekkum DW; Hagenbeek A
    Leuk Res; 1984; 8(6):953-63. PubMed ID: 6595483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of treatment with 13-cis-retinoic acid and ara-C on the hematopoietic stem cells of patients with myelodysplastic syndromes].
    García Marco J; Miguel Sosa A; García Conde J; Miguel García A; Arbona C; Escrig V; Benet I; Navarro I; Ruiz A; Carbonell F
    Sangre (Barc); 1994 Aug; 39(4):241-4. PubMed ID: 7985051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.
    Laughlin MJ; Kirkpatrick G; Sabiston N; Peters W; Kurtzberg J
    Ann Hematol; 1993 Dec; 67(6):267-76. PubMed ID: 7506580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of rh-cytokines on the sensitivity of normal human CFU-GM progenitors to Ara-C and on the S-phase activity of light density human bone marrow cells.
    Smith MA; Smith JG; Provan AB; Singer CR
    Leuk Res; 1994 Feb; 18(2):105-10. PubMed ID: 7509013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of cytosine arabinoside on the differentiation of granulocyte-monocyte progenitors (CFU-GM) and myeloid leukemia blasts (CFU-L) in vitro].
    Wächter M; Goldschmidt H; Blau W; Elstner E; Ihle R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(6):927-34. PubMed ID: 2467864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of interferon alpha with either Ara-C or ATRA in vitro reduces the selective action of interferon against CML CFU-GM.
    Marley SB; Davidson RJ; Goldman JM; Gordon MY
    Leukemia; 2000 Aug; 14(8):1396-400. PubMed ID: 10942234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of acetyl-Ser-Asp-Lys-Pro (AcSDKP) on human hematopoietic progenitor cells in short-term and long-term bone marrow cultures.
    Jackson JD; Ozerol E; Yan Y; Ewel C; Talmadge JE
    J Hematother Stem Cell Res; 2000 Aug; 9(4):489-96. PubMed ID: 10982247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-CFU-f: young-type stromal stem cells in murine bone marrow following administration of DNA inhibitors.
    Ben-Ishay Z; Prindull G; Sharon S; Borenstein A
    Int J Cell Cloning; 1986 Mar; 4(2):126-34. PubMed ID: 3958511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ways of minimising hematopoietic damage induced by radiation and cytostatic drugs--the possible role of inhibitors.
    Tubiana M; Carde P; Frindel E
    Radiother Oncol; 1993 Oct; 29(1):1-17. PubMed ID: 8295982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.